Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.

Honglu Ding,Qiuxia Yang,Yize Mao,Dailei Qin,Zehui Yao,Ruiqi Wang,Tao Qin,Shengping Li

Journal of inflammation research（2023）

引用 4|浏览18

暂无评分

摘要

Owing to the rapid and simple analysis of peripheral blood, baseline SAA might be a useful clinical biomarker, not only as a prognostic biomarker for patients with APC, but also as a guide for the selection of chemotherapy regimens.

查看译文

关键词

advanced pancreatic cancer,biomarker,chemotherapy,prognosis,serum amyloid A

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要